REDHILL BIOPHARMA LTD. Current Payables For Purchase Of Noncurrent Assets
REDHILL BIOPHARMA LTD. (RDHL) had Current Payables For Purchase Of Noncurrent Assets of $11.16 million as of 2022-12-31, per its 20-F filed 2024-04-08.
Discontinued › Notes
ifrs-full:CurrentPayablesForPurchaseOfNoncurrentAssets · last filed 2024-04-08
- 2022-12-31: Current Payables For Purchase Of Noncurrent Assets $11.16M.
- 2022-06-30: Current Payables For Purchase Of Noncurrent Assets $15.63M.
- 2021-12-31: Current Payables For Purchase Of Noncurrent Assets $16.58M.
- 2021-06-30: Current Payables For Purchase Of Noncurrent Assets $14.92M.
| Period end | Current Payables For Purchase Of Noncurrent Assets |
|---|---|
| 2022-12-31 | $11.16M 20-F · filed 2024-04-08 |
| 2022-06-30 | $15.63M 6-K · filed 2022-11-07 |
| 2021-12-31 | $16.58M 20-F · filed 2023-04-28 |
| 2021-06-30 | $14.92M 6-K · filed 2021-08-26 |
| 2020-12-31 | $17.55M 20-F · filed 2022-03-17 |
| 2018-06-30 | $500.00K 6-K · filed 2018-08-30 |
| 2017-12-31 | $1.00M 20-F · filed 2019-02-26 |
| 2016-12-31 | $2.00M 20-F · filed 2018-02-22 |